NCT07119346

Brief Summary

This randomized controlled trial will evaluate the efficacy of ultrasound-guided external oblique intercostal fascial plane (EOI) block in reducing intraoperative and postoperative pain in pediatric patients undergoing laparoscopic gastrostomy under general anesthesia. Forty patients aged 3-18 years will be randomly allocated to receive either bilateral EOI block with 0.25% ropivacaine or sham block with normal saline. Primary outcome is percent change in heart rate at surgical incision. Secondary outcomes include intraoperative fentanyl use, perioperative analgesic requirements, postoperative pain scores (r-Face, Legs, Activity, Cry, Consolability(r-FLACC) and Pediatric Pain Profile), Analgesia Nociception Index values, and analgesia-related adverse events.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
24mo left

Started Aug 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Aug 2025May 2028

Study Start

First participant enrolled

August 1, 2025

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

August 11, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 13, 2025

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

2.8 years

First QC Date

August 11, 2025

Last Update Submit

August 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percent change in heart rate at surgical incision

    Post-incision HR - Pre-incision HR) / Pre-incision HR × 100

    At surgical incision (baseline immediately before incision and within 10 minutes after incision).

Secondary Outcomes (11)

  • Intraoperative fentanyl use

    From induction of anesthesia to end of surgery.

  • Percent change in mean arterial pressure at incision

    At surgical incision (baseline immediately before incision and within 10 minutes after incision).

  • Intraoperative max-min heart rate

    Intraoperative period (skin incision to end of surgery).

  • Intraoperative max-min mean arterial pressure

    Intraoperative period (skin incision to end of surgery).

  • ANI time-weighted average outside target (50-80)

    From induction of anesthesia to end of anesthesia (arrival to PACU).

  • +6 more secondary outcomes

Study Arms (2)

EOI block group

EXPERIMENTAL
Procedure: EOI block

control group

SHAM COMPARATOR
Procedure: sham block

Interventions

EOI blockPROCEDURE

EOI block with 0.25% ropivacaine 1 mL/kg (max 40 mL) bilaterally under ultrasound guidance

EOI block group
sham blockPROCEDURE

Sham block with equal volume of normal saline bilaterally under ultrasound guidance

control group

Eligibility Criteria

Age3 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Scheduled for laparoscopic gastrostomy at Seoul National University Children's Hospital
  • Age ≥3 and \<18 years

You may not qualify if:

  • Unstable vital signs
  • Contraindications to ropivacaine or opioids
  • Severe hepatic or renal dysfunction
  • Other investigator-determined ineligibility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Children's Hospital

Seoul, 110-744, South Korea

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

August 11, 2025

First Posted

August 13, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2028

Last Updated

August 13, 2025

Record last verified: 2025-08

Locations